Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 26.99 | 28.95 |
| PEG Ratio (TTM) | 0.27 | 5.02 |
| P/S Ratio (TTM) | 24.08 | 89.85 |
| P/B Ratio (TTM) | 1.07 | 74.05 |
| P/FCF Ratio (TTM) | 146.10 | 65.18 |
| Price to 5YR AVG Earnings Ratio | 16.82 | 26.86 |
| Price to 5YR AVG FCF Ratio | 13.50 | 50.98 |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.07% | 4.62% |
| ROE (TTM) | 3.93% | 8.81% |
| Net Profit Margin (TTM) | 92.95% | -10.17% |
| ROIC 5YR AVG | 5.44% | 17.25% |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | N/A | 52.11% | 22.17% |
| Revenue | N/A | 60.75% | 26.53% |
| Net Income | N/A | 51.26% | 20.64% |
| Cash Flow | N/A | 592.80% | 435.44% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.42 | 5.91 |
| Quick Ratio (TTM) | 0.42 | 5.77 |
| D/E Ratio (TTM) | 0.26 | 0.70 |
| Interest Coverage (TTM) | 2.58 | 18.00 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | N/A | 6.37 |
| LTL to 5YR AVG FCF | 3.35 | 2.48 |
| Shares Outstanding Growth 5YR AVG | -1.53% | 13.17% |